News & Events

StageBio Update: Committed to serving you

At this time our production schedule is on track, with no unplanned delays.


Dear StageBio Client,

In this time of unprecedented challenges caused by COVID-19, we wanted to assure you that StageBio is committed to serving our clients while protecting the health and well-being of our team. At this time our production schedule is on track, with no unplanned delays.

Having activated our business continuity plan, we continue to implement appropriate actions to ensure our ability to meet study deadlines. This includes flexible schedules, staff working from home, ongoing staff training, travel restrictions and daily cleaning procedures as outlined by the CDC. We have also taken steps to avoid shortages of needed supplies.

StageBio is actively consulting on COVID-19 vaccine projects, bringing our specialized expertise in preclinical histopathology and infectious disease to this critical, time-sensitive task. If we can help advance your research—whether associated with COVID-19 or any other studies—we welcome the opportunity to assist you.

If you need assistance or would like more information on how StageBio is working to address the challenge of COVID-19, please contact us today.  



Client Services


Back to Index

Upcoming Events

ASGCT (American Society of Gene and Cell Therapy)

May 16-19, 2022, Walter E. Washington Convention Center, Washington, D.C.

Society of French Pathology Toxicology

May 19-20, Toulouse, France
Listen to our presentation by Dr. Serge Rousselle, CSO, on the scientific value of histopathological evaluation during the nonclinical safety assessment of medical devices

Popular Posts

Learn more about StageBio’s COVID-19 response